Norak Biosciences Inc. believes that its Transfluor technology is a universal platform for identifying any G protein-coupled receptor, but the company has lacked an accompanying technology for imaging Transfluor's results in a high throughput fashion. That piece of the puzzle was added last week through a partnership with Amersham Pharmacia Biotech Inc. for the latter's Leadseeker cell analysis system.

The premise of Transfluor is that all GPCRs exhibit the property of desensitization, in which